{"id":"NCT01314716","sponsor":"Gilead Sciences","briefTitle":"Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis","officialTitle":"A Phase 3, Double-Blind, Multicenter, Randomized, Placebo-Controlled Trial Evaluating Repeated Courses of Aztreonam for Inhalation Solution/Aztreonam 75 mg Powder and Solvent for Nebuliser Solution in Subjects With Non-CF Bronchiectasis and Gram-Negative Endobronchial Infection (AIR-BX2)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-04","primaryCompletion":"2013-04","completion":"2013-07","firstPosted":"2011-03-14","resultsPosted":"2014-04-16","lastUpdate":"2014-04-16"},"enrollment":274,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Bronchiectasis"],"interventions":[{"type":"DRUG","name":"AZLI","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"AZLI-AZLI","type":"EXPERIMENTAL"},{"label":"Placebo-AZLI","type":"PLACEBO_COMPARATOR"}],"summary":"The AIR-BX2 study enrolled people with non-cystic fibrosis (non-CF) bronchiectasis and gram-negative airway infection. Participants received two 28-day courses of either Aztreonam for Inhalation Solution (AZLI) or placebo taken 3 times a day. Each course was followed by a 28-day off-drug period. Following the two blinded courses, all participants received a 28-day course of open-label AZLI then were followed for an additional 56 days.","primaryOutcome":{"measure":"Change in QOL-B Respiratory Symptoms Score at Day 28","timeFrame":"Baseline to Day 28","effectByArm":[{"arm":"AZLI-AZLI","deltaMin":8.2,"sd":17.13},{"arm":"Placebo-AZLI","deltaMin":3.2,"sd":14.67}],"pValues":[{"comp":"OG000 vs OG001","p":"0.011"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":8},"locations":{"siteCount":85,"countries":["United States","Australia","Belgium","Canada","France","Germany","Italy","Netherlands","Spain","United Kingdom"]},"refs":{"pmids":["25154045"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":18,"n":135},"commonTop":["Cough","Sputum increased","Dyspnoea","Sputum discoloured","Fatigue"]}}